The University of Granada is a public university located in the city of Granada, Spain, and founded in 1531 by Emperor Charles V. With approximately 80,000 students, it is the fourth largest university in Spain. Apart from the city of Granada, UGR also has campuses in Ceuta and Melilla.

During the past decade, University of Granada conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Granada" #1 sponsor was "Universidad de Granada" with 24 trials, followed by "Competence Centre on Health Technologies" with 1 trials sponsored, "Lithuanian University of Health Sciences" with 1 trials sponsored, "Mercedes García de Quesada" with 1 trials sponsored and "University of Malaga" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Granada" #1 collaborator was "Universidad de Granada" with 2 trials as a collaborator, "University Hospital Virgen de las Nieves" with 2 trials as a collaborator, "Andalusian School of Public Health" with 1 trials as a collaborator, "Asociación Española contra el Cáncer" with 1 trials as a collaborator and "Biodonostia Health Research Institute (Biodonostia HRI)" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "University of Granada" are "Fibromyalgia" (4 trials), "Breast Neoplasms" (3 trials), "Breast Neoplasm" (2 trials), "Obstructive Sleep Apnea" (2 trials) and "Airway Disease" (1 trials). Many other conditions were trialed in "University of Granada" in a lesser frequency.

Most popular intervention types in "University of Granada" are "Other" (15 trials), "Behavioral" (8 trials), "Device" (5 trials), "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATENTO-B" (1 trials), "ATENTO-T" (1 trials), "ATOPE-B" (1 trials), "ATOPE-I" (1 trials) and "Cervical motor control" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Granada" are 16 trials for "All" genders, 10 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Granada". undefined are not yet recruiting, 5 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in University of Granada, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Granada, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 21 trials that are defined as “Not Applicable".